Evidence map›Paper›PMID 30637404›Full record

ArticleMicrobiology resource announcements2019

Draft Genome Sequence of the Novonestmycin-Producing Strain Streptomyces sp. Z26, Isolated from Potato Rhizosphere in Morocco.

Anina Buchmann, Carolina Cano-Prieto, Ahmed Nafis, Mustapha Barakate, Mohamed Baz, Lahcen Hassani, Nico Ortlieb, Timo H J Niedermeyer, Harald Gross

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology resource announcements, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Complete genome sequence of antibiotic-producingMicrobiology resource announcements · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anina BuchmannDepartment of Pharmaceutical Biology, Pharmaceutical Institute, University of Tübingen, Tübingen, Germany.
Carolina Cano-PrietoDepartment of Pharmaceutical Biology, Pharmaceutical Institute, University of Tübingen, Tübingen, Germany.
Ahmed NafisLaboratory of Biology and Biotechnology of Microorganisms, Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakech, Morocco.
Mustapha BarakateLaboratory of Biology and Biotechnology of Microorganisms, Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakech, Morocco.
Mohamed BazLaboratory of Biology and Biotechnology of Microorganisms, Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakech, Morocco.
Lahcen HassaniLaboratory of Biology and Biotechnology of Microorganisms, Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakech, Morocco.
Nico OrtliebGerman Centre for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Timo H J NiedermeyerGerman Centre for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0003-1779-7899
Harald GrossDepartment of Pharmaceutical Biology, Pharmaceutical Institute, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-0731-821X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptomyces sp. strain Z26 exhibited antifungal activity and turned out to be a producer of the secondary metabolites novonestmycin A and B. The 6.5-Mb draft genome gives insight into the complete secondary metabolite production capacity and builds the basis to find and locate the biosynthetic gene cluster encoding the novonestmycins.

Identifiers

PMID30637404
PMCPMC6318375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.